Artificial Intelligence in Vaccine Design
A special issue of Vaccines (ISSN 2076-393X).
Deadline for manuscript submissions: closed (30 December 2023) | Viewed by 794
Special Issue Editors
Interests: infectious disease; malaria; virus; cancer; medicinal chemistry; natural compounds
Special Issues, Collections and Topics in MDPI journals
Interests: molecular pharmacology; cancer immunotherapy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
In last decade, the areas of data science, informatics, and artificial intelligence (AI) have all experienced great expansion. Machine learning-based (ML) models have provided quick and affordable ways to find efficient treatments and bioinformatics has changed immunology research leading to the discipline of immunoinformatics, in particular in field of infectious disease and virus. The aim of this Special Issue is to bring tools, methods, approaches and potential agents that will provide with new insights for developing new strategies for vaccine or its adjuvant. Experimental papers, review articles and commentaries are all welcome.
Dr. Paolo Coghi
Dr. Xingxing Fan
Dr. Alex Po Leung
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- artificial intelligence
- infectious diseases
- vaccine
- machine learning
- virus
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.